...
首页> 外文期刊>The journal of obstetrics and gynaecology research >Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
【24h】

Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.

机译:宫腔镜滚球子宫内膜消融术是子宫腺肌病伴月经过多和/或痛经的替代疗法。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: The aim of this study was to assess the long-term effectiveness and safety of hysteroscopic rollerball endometrial ablation as a surgical management of adenomyosis with menorrhagia and/or dysmenorrhea. We compared the results of patients who underwent pretreatment with gonadotropin-releasing hormone (GnRH) agonist with the results of those who did not. METHODS: A retrospective study included 190 adenomyotic patients who suffered from menorrhagia and/or dysmenorrhea and underwent hysteroscopic rollerball endometrial ablation. Main outcome measures were rates of successful operation, complications, improvement of abnormal uterine bleeding and pelvic pain after the surgery. RESULTS: The majority of the patients (142, 74.7%) underwent hysteroscopic rollerball endometrial ablation during the early proliferative phase of the menstrual cycle. The rest were operated on after GnRH agonist pretreatment for 6-8 weeks. Ablations were successfully performed on all patients in a day surgery setting. The average operation time was 36.3 +/- 7.1 min. The mean glycine deficit was 583.4 +/- 247.3 mL. The ablation in the no-pretreatment group took a significantly longer time and had more glycine absorption compared to the GnRH agonist pretreatment group (P < 0.0001). Mean postoperative follow-up duration was five years (range 1-10 years). A total of 187 patients (98.4%) who had undergone hysteroscopic endometrial ablation reported decreased bleeding: amenorrhea in 58 (30.5%), hypomenorrhea in 78 (41.1%), and eumenorrhea in 51 (26.8%) patients. Three patients (1.6%) underwent hysterectomy due to symptoms recurrence. A total of 165 (86.8%) patients with dysmenorrhea reported either reduced or no dysmenorrhea. There was no significant difference in the efficacy of hysteroscopic rollerball endometrial ablation between patients who underwent pretreatment with GnRH agonists and those who did not. No major complications related to the procedure were reported. CONCLUSIONS: Hysteroscopic rollerball endometrial ablation as a surgical management of menorrhagia and dysmenorrhea that develops in patients with adenomyosis is an effective and safe procedure. It can reduce the need for the unnecessary major surgery of hysterectomy.
机译:目的:本研究的目的是评估宫腔镜滚球子宫内膜切除术作为子宫腺肌病伴月经过多和/或痛经的手术治疗的长期有效性和安全性。我们将接受促性腺激素释放激素(GnRH)激动剂预处理的患者的结果与未接受促性腺激素释放激素(GnRH)激动剂的患者的结果进行了比较。方法:一项回顾性研究包括190名患有月经过多和/或痛经并接受宫腔镜下滚珠子宫内膜切除术的子宫腺肌病患者。主要结局指标为手术成功率,并发症,术后异常子宫出血和骨盆疼痛的改善。结果:大多数患者(142,74.7%)在月经周期的早期增生期接受宫腔镜下滚球子宫内膜消融术。其余的在GnRH激动剂预处理6-8周后进行手术。在一天手术的情况下,所有患者均成功完成了消融。平均手术时间为36.3 +/- 7.1分钟。平均甘氨酸缺乏症为583.4 +/- 247.3 mL。与GnRH激动剂预处理组相比,无预处理组的消融花费了更长的时间,并且甘氨酸吸收更高(P <0.0001)。术后平均随访时间为五年(1-10年)。共有187例(98.4%)接受宫腔镜子宫内膜切除术的患者报告出血减少:闭经58例(30.5%),月经减少78例(41.1%)和月经不育51例(26.8%)。由于症状复发,三名患者(1.6%)接受了子宫切除术。共有165名(86.8%)痛经患者报告痛经减轻或无痛经。在接受GnRH激动剂预处理的患者与未接受GnRH激动剂预处理的患者之间,宫腔镜下滚球子宫内膜消融的疗效没有显着差异。没有报告与手术相关的重大并发症。结论:宫腔镜下滚球子宫内膜消融术是对子宫腺肌病患者发展的月经过多和痛经的一种外科手术治疗方法,是一种安全有效的方法。它可以减少不必要的子宫切除大手术的需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号